Patents Assigned to China Pharmaceutical University
  • Publication number: 20130079393
    Abstract: Isoflavone fatty acid ester derivatives of formula (I) or (II), the preparation method thereof and the pharmaceutical compositions containing such compounds are disclosed. The uses of such compounds in preparation of medicaments for preventing or treating hyperlipidemia, obesity or type II diabetes are also disclosed.
    Type: Application
    Filed: March 1, 2010
    Publication date: March 28, 2013
    Applicant: CHINA PHARMACEUTICAL UNIVERSITY
    Inventors: Hua Xiang, Wei Zhao, Hong Xiao, Yao Yao, Renling Ma, Lei Qian, Xiaobo Li, Qidong You, Qingjiang Liao
  • Publication number: 20110136916
    Abstract: The present invention relates to the field of natural drugs, particularly to 6-shogaol for using in a method for the treatment of leukemia. The present invention provides a method for treating leukemia by applying a therapeutically effective dose of 6-shogaolt and this therapeutic method can be used for treating leukemia in mammals including human being.
    Type: Application
    Filed: November 3, 2010
    Publication date: June 9, 2011
    Applicant: China Pharmaceutical University
    Inventors: Ping Li, Yongbo Peng, Lianwen Qi, Xiaodong Wen, Jiang Ma, Ping Zhou, Lei Zhang, Qun Liu, Ehu Liu, Jun Chen
  • Patent number: 7820692
    Abstract: A kind of tetrahydro isoquinoline derivatives (I), their preparation methods, medicine compositions and medicinal uses thereof, especially their uses as ?-opioid receptor excitant in pain relieving, which belongs to the medicine chemistry. The substituents R1, R2, R3, R4 of general formula (I) are defined as the description.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: October 26, 2010
    Assignees: China Pharmaceutical University, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Yangtze River Pharmaceutical Group Co., Ltd.
    Inventors: Yungen Xu, Jinggen Liu, Ting Guo, Dechuan Wang, Tianjiang Sun, Hongguo Lu
  • Publication number: 20100210822
    Abstract: Provided is a kind of modified recombinant human endostatin that has the structure of CH3O—(CH2CH2O)m—CH2CH2CH2—N?H-Endostar, wherein the average molecular weight of CH3O—(CH2CH2O)m—CH2CH2CH2— is 20-40 kD. The modified recombinant human endostatin enhances the stability in vivo, improves blood drug concentration, prolongs half-life, markedly increases the activity of inhibiting the endothelial cells proliferation, thus reduces drug dosage and decreases administration frequency. Its application for preparing anti-tumor pharmaceutical compositions is also provided.
    Type: Application
    Filed: September 4, 2008
    Publication date: August 19, 2010
    Applicants: JIANGSU SIMCERE PHARMACEUTICAL R&D CO., LTD., CHINA PHARMACEUTICAL UNIVERSITY, Shandong Xiansheng Maidejin Biologial Pharmaceutia l Co. Ltd
    Inventors: Wenbing Yao, Hong Tian, Xiangyang Xu, Hairui Li, Yue Dong, Xiangdong Gao
  • Patent number: 7772230
    Abstract: The present invention provides a chroman compound of formula (I) and its pharmaceutical salt, methods of its preparation and its pharmaceutical applications. Wherein: X is O or S; n is for 2, 3 or 4; R1 is 6-substituted or 7-substituted halogen, C1-4alkyl, C1-4alkoxyl, benzyloxy, carbamoyl; R2 is nitrogen-containing five-membered or six-membered substituted heterocyclic ring selected from piperidinyl, morpholinyl, N-methyl-piperazinyl, N-(2-ethoxyl)piperazinyl, pyrrolyl, pyrazolyl or imidazolyl. The compounds are useful to prepare medicaments for treating cardiovascular diseases, their preparation employs mild reaction conditions, the raw material are plenty and easy to be obtained, and the operation and post-treatment in the preparation are simple.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: August 10, 2010
    Assignee: China Pharmaceutical University
    Inventors: Qidong You, Lvpei Du, Minyong Li, Lin Xia
  • Publication number: 20080103307
    Abstract: The present invention provided a chroman compound, the method of its preparation and pharmaceutical applications. The compound are represented by formula (I) and its pharmaceutical salt, where in :x is for O or S; n is for 2, 3 or 4; R1 is 6-situ or 7-situ halogen, C1-4alkyl, C1-4alkyoxyl, benzyloxy, acylamino; R2 is nitrogen-containing pentatomic or hexahydric substituted heterocyclic ring. The compound is useful to prepare anti-arrhythmic drugs, the reaction conditions of the method are mild, the raw material are plenty and easy to be obtained, and the operation and post-treatment are simple.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 1, 2008
    Applicant: CHINA PHARMACEUTICAL UNIVERSITY
    Inventors: Qidong You, Lvpei Du, Minyong Li, Lin Xia
  • Patent number: 6596321
    Abstract: This invention relates to a pharmaceutical composition used for treating cardiovascular diseases and a method for preparing it. The pharmaceutical composition mainly contains polysacchrides, saponins and amino acids extracted from Radix ginseng, Radix ophiopogonis and Fructus schisandrae chinensis. The method of preparing it includes the following steps: Radix ginseng, Radix ophiopogonis and Fructus schisandrae chinensis are decocted together in water; water extract or eluate is precipitated with alcohol or acetone, treated with macroporous adsorption resin and with ion exchange resin, and then separated to obtain pharmaceutical composition containing effective fractions of polysacchrides, saponins and amino acids. The above mentioned pharmaceutical composition can be formed into various preparations by mixing with any pharmaceutically acceptable auxiliary materials.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: July 22, 2003
    Assignees: China Pharmaceutical University, Ningbo Asia-Pacific Biotechnology Ltd.
    Inventors: Yongqing Yan, Minghui Tang, Danni Zhu, Shufei Zhuang
  • Patent number: 5470852
    Abstract: A tetrahydroprotoberberine quaternary ammonium compound represented by the formula: ##STR1## wherein R.sub.1, R.sub.2, R' and X are as defined in the specification. A method of preparing the compound is provided. The compounds can suppress arrhythmia and ventricular fibrillation, protect against myocardial ischemia, and can be conveniently orally administered.
    Type: Grant
    Filed: October 31, 1994
    Date of Patent: November 28, 1995
    Assignees: China Pharmaceutical University, Administrative Center of New Drug Research, The State Pharmaceutical Administration of China
    Inventors: Sixun Peng, Dezai Dai, Zhenya Huang, Wenlong Huang, Youqun Wang, Can Zhang, Feng Yu
  • Patent number: 5430054
    Abstract: The invention provides methods of preparing a male antifertility agent composed of a diterpene lactone compound obtained from plants of the genus Tripterygium, the diterpene lactone compounds obtained from that method, and the use of the compounds as an antifertility agent.
    Type: Grant
    Filed: December 18, 1990
    Date of Patent: July 4, 1995
    Assignees: Jiangsu Family Planning Institute, China Pharmaceutical University, Institute of Dermatology, Chinese Academy of Medical Sciences
    Inventors: Shoa-Zhen Qian, Jia-Run Zheng, Xie-Yu Lu, Peng-Cheng Ma, Chong-Pu Zhang, Yun Chen, Ke-Xian Gu, Wen-Yan Xu, Zheng-Xing Zhang, Long-Sheng Sheng, Deng-Kui An, Ye Xu, Qi-Tai Zhen